Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Dose Exploration of Remimazolam Tosilate for Injection for Induction and Maintenance of General Anesthesia Intubation for Elective Short-term Surgery in Adults: a Multi-center, Randomized, Double-blind Clinical Study

NCT04908553 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT04908553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04908553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Dose Exploration of Remimazolam Tosilate for Injection for Induction and Maintenance of General Anesthesia Intubation for Elective Short-term Surgery in Adults: a Multi-center, Randomized, Double-blind Clinical Study
Lead sponsor
Tongji Hospital
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2021
Completion date
May 31, 2025
Enrollment
650 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypotension during surgery